|
Summary of Expertise:
|
Listed with other top experts in: |
|
He has worked in the development and manufacturing of chewable tablets either for the delivery of locally (oral) acting drugs with a variety of excipients and basic tableting technology and in the development of medicinal candy products enclosing vitamins flavoring agents and sweeteners.
|
|
|
He developed and manufactured controlled release solid dose forms including: hydrophyllic, hydrophobic matrix systems, Alginate based controlled release matrices, amd guar gum matrices for control release of actives to the colon.
|
|
|
He developed controlled release drug delivery systems based in multi matrix systems, floating controlled release drug delivery systems and polymer based drug delivery devices.
|
|
|
He worked in new drug delivery technologies to be applied to veterinary medicine and human medicine as well. He developed floating controlled release devices to be used in water disinfection and vehiculizing biologic larvicide products.
He developed and produced osmotic driven delivery devices and also patented a multi-layer delivery device.
|
|
|
He is devoted to developing and patenting novel delivery systems that could be easily scaled up using general in use pharmaceutical production machinery.
|
|
|
He developed oral solid, liquid and mucoadhesive drug delivery products. He actually works in the field of effervescent solid products either in the form of powder or tablets.
|
|
|
Is responsible for the pre-formulation, formulation assays and scale-up to production of pharmaceutical forms. He is responsible for the development of formulations that do not infringe patent rights and that are bio-equivalent to the original ones.
|
|
|
He develops softgel capsule formualtions attempting to be original and not upon infriging patent rights. He conducts pre stability assays, stability and scaling-up of formualtions to third party manufacturers or to his company's facility.
|
|
|
He worked in solid dose manufacturing areas in troubleshooting of new and existing formulations. He has responsibility in technology transfer and changing production processes.
|
|
|
He joined the experience gained through the improvement in drug dissolution technologies for soft gel and liquid formulations and applied it to wet granulation to improve the dissolution performace of solid dose forms.
|
|
|
He worked jointly with exipient manufacturers in the improvement of coating formulations to be applied to solid dose forms.
|
|
|
He has a broad experience in solid dose forms from the development to the manufacturing stage.
|
|
|
He helped in solving manufactuing problems related to the tableting of powders and also quality problems associated with it.
|
|
|
He developed and worked with almost all types of tablet dose forms. He has good skills for the development of a tablet based in a new API whose characteristics are not well known.
|
|
|
He developed and worked with coatings from "cosmetic" to functional ones. He solved manufacturing problems related to coated dose forms.
|
|
|
He is aware of the fact that one of the ways to gain success in the pharmaceutical market is through the development of innovative drug dosage forms.
|
|
|
He was involved in the development and change of propellants for aerosol formulations MDI and DPI development.
|
|
|
He worked in innovative dosage forms and helped meliorate those with stability problems.
|
|
Show Secondary and Basic Areas of Expertise |